2-147900020-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001616.5(ACVR2A):​c.528+122A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.591 in 1,135,974 control chromosomes in the GnomAD database, including 204,465 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 20916 hom., cov: 32)
Exomes 𝑓: 0.61 ( 183549 hom. )

Consequence

ACVR2A
NM_001616.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.00

Publications

10 publications found
Variant links:
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.641 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACVR2ANM_001616.5 linkc.528+122A>G intron_variant Intron 4 of 10 ENST00000241416.12 NP_001607.1
ACVR2ANM_001278579.2 linkc.528+122A>G intron_variant Intron 5 of 11 NP_001265508.1
ACVR2ANM_001278580.2 linkc.204+122A>G intron_variant Intron 4 of 10 NP_001265509.1
ACVR2AXM_047446292.1 linkc.204+122A>G intron_variant Intron 4 of 10 XP_047302248.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACVR2AENST00000241416.12 linkc.528+122A>G intron_variant Intron 4 of 10 1 NM_001616.5 ENSP00000241416.7

Frequencies

GnomAD3 genomes
AF:
0.499
AC:
75684
AN:
151818
Hom.:
20911
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.248
Gnomad AMI
AF:
0.640
Gnomad AMR
AF:
0.513
Gnomad ASJ
AF:
0.607
Gnomad EAS
AF:
0.485
Gnomad SAS
AF:
0.660
Gnomad FIN
AF:
0.628
Gnomad MID
AF:
0.436
Gnomad NFE
AF:
0.610
Gnomad OTH
AF:
0.483
GnomAD4 exome
AF:
0.605
AC:
595359
AN:
984038
Hom.:
183549
AF XY:
0.607
AC XY:
299193
AN XY:
492562
show subpopulations
African (AFR)
AF:
0.228
AC:
4922
AN:
21544
American (AMR)
AF:
0.492
AC:
10805
AN:
21982
Ashkenazi Jewish (ASJ)
AF:
0.594
AC:
10350
AN:
17424
East Asian (EAS)
AF:
0.495
AC:
16686
AN:
33698
South Asian (SAS)
AF:
0.651
AC:
37359
AN:
57354
European-Finnish (FIN)
AF:
0.617
AC:
24745
AN:
40084
Middle Eastern (MID)
AF:
0.463
AC:
1961
AN:
4240
European-Non Finnish (NFE)
AF:
0.622
AC:
463141
AN:
744294
Other (OTH)
AF:
0.585
AC:
25390
AN:
43418
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
11031
22063
33094
44126
55157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11270
22540
33810
45080
56350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.498
AC:
75712
AN:
151936
Hom.:
20916
Cov.:
32
AF XY:
0.504
AC XY:
37419
AN XY:
74264
show subpopulations
African (AFR)
AF:
0.248
AC:
10287
AN:
41482
American (AMR)
AF:
0.513
AC:
7820
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.607
AC:
2107
AN:
3472
East Asian (EAS)
AF:
0.485
AC:
2502
AN:
5160
South Asian (SAS)
AF:
0.661
AC:
3181
AN:
4816
European-Finnish (FIN)
AF:
0.628
AC:
6631
AN:
10562
Middle Eastern (MID)
AF:
0.441
AC:
128
AN:
290
European-Non Finnish (NFE)
AF:
0.610
AC:
41445
AN:
67896
Other (OTH)
AF:
0.486
AC:
1027
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1768
3536
5304
7072
8840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.561
Hom.:
30631
Bravo
AF:
0.470
Asia WGS
AF:
0.598
AC:
2077
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
7.9
DANN
Benign
0.84
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2288190; hg19: chr2-148657589; API